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Nucleotides choose origins
 
n vertebrate cells, not all potential DNA replication origins 
fire in each S phase, but it is unclear what parameters control 
that decision. Mauro Anglana, Michelle Debatisse (Institut Curie, 
Paris, France), and colleagues find that nucleotide availability can 
determine which origins are activated.
Under normal conditions (when nucleotides were readily 
available), initiation occurred predominantly at one site within 
the AMPD2 locus. Only in a few cases did minor sites fire instead. 
Firing of the dominant origin seems to prevent other nearby 
origins from initiating replication, as only an origin spaced far 
from the major origin was used simultaneously.
 
 
 
Cells with limited nucleotide avail-
ability, however, replicated from a wider 
variety of origins. Although the predom-
inant origin was not used as often, 
simultaneous activation from multiple 
minor sites was more common. Firing 
efficiency of competent origins has been 
attributed mainly to epigenetic controls, 
including nuclear organization. But 
Debatisse says “things that are far simpler 
can also determine the choice of origin, 
including nucleotide pools. And it’s 
completely reversible from one cell cycle to another.”
A change in origin selection strategy probably equalizes genome 
replication times. Low nucleotide levels slowed replication fork 
progression, but the increased number of actively firing origins 
compensated for this difference, thus resulting in equally long 
S phases. Now, Debatisse hopes to identify proteins that localize 
to an origin in a nucleotide-dependent manner. 
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Nucleotide levels can 
alter replication initia-
tion site selection.
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Losing self-awareness
 
aste is rife in the immune system, based on a report 
from Hedda Wardemann, Michel Nussenzweig 
(Rockefeller University, New York, NY), and colleagues. 
The group has determined that more than half of the human 
B cell antibody population is removed before maturation.
The removal is a conse-
quence of antibody gene 
rearrangement—a random 
process that is certain to 
generate some autoreactive 
antibodies. Nussenzweig’s 
group now shows just how 
often autoreactivity occurs by 
identifying autoreactive B cells 
at different stages of develop-
ment. Between 55% and 75% 
of the antibodies made by early 
immature B cells react against 
self antigens. These potentially dangerous antibodies are 
removed from the repertoire at two checkpoints: the number 
of self-reactive antibody-producing B cells were halved from 
within the bone marrow and then halved again after entering 
the blood stream. Also, nearly 90% of developing B cells 
producing polyreactive antibodies, whose promiscuity 
is probably a risk to the host, were removed at the marrow 
checkpoint.
These studies will help determine how autoimmune 
diseases arise. “Any problem in the checkpoints that would 
allow self-reactive B cells to get through might be dangerous,” 
says Wardemann. “We determined the numbers in normal, 
healthly donors. If we compare this to autoimmune patients, 
we should get an idea of where the problem lies.”
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Most self-reactive antibodies 
(green) are filtered from the 
developing immune system.
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The healing power of Ron
 
blood-localized growth factor has-
tens wound healing by pulling an 
integrin switcharoo on skin cells. The 
exchange, shown by Massimo Santoro 
(University of Piemonte Orientale, 
Novara, Italy) and colleagues, both 
releases adhered cells and promotes 
migration.
Skin cells stick to the basement mem-
brane through hemidesmosome (HD)-
localized integrin 
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. Santoro et al. 
show that the MSP growth factor releases 
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 from HDs and activates a migratory 
integrin, 
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, instead. Binding of MSP 
to its tyrosine kinase receptor, Ron, led 
to phosphorylation of both Ron and 
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, 
which introduced binding sites for 14-3-3 
A 
 
scaffolding proteins into both proteins. 
Through typical 14-3-3 dimerization, the 
phosphorylation thus creates a complex 
containing Ron and 
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.
MSP-induced Ron/integrin complexes 
were seen at the leading edge of migrat-
ing cells and corresponded with loss of 
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 from HDs. At the lamellipodia, 
phosphorylated 
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 switched to 
a signaling role. 
Along with Ron, 
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 activated 
transcription 
pathways that 
promote migration 
via production of 
matrix metalloproteases and additional 
MSP.
The venue change for 
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 had a 
ripple effect on another integrin. Before 
MSP stimulation, 
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, was stuck at cell–
cell contacts, apparently in an inactive 
complex with Ron. But Ron exchanged 
partners upon phosphorylation, thus 
allowing 
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 to move to focal contacts, 
where it interacts with actin fibers to 
promote migration. This may explain 
why application 
of MSP to open 
wounds shortened 
the healing time 
for mice.
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 5:257–271. Wounds heal more quickly with MSP (left).
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